4-(Bromomethyl)benzoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(Bromomethyl)benzoate
• 化学式: C8H6BrO2-
• 分子量: 214.04
• InChiKey: CQQSQBRPAJSTFB-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  40.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (3,4-Dichlorophenyl)[4-(4-phenylphenyl)(1,3-thiazol-2-yl)]amine 、 4-(Bromomethyl)benzoate 在 methyl 作用下， 生成 、 4-({(3,4-Dichlorophenyl)[4-(4-phenylphenyl)(1,3-thiazol-2-yl)]amino}methyl)benzoic acid
  参考文献：
  名称：

  Organosulfur inhibitors of tyrosine phosphatases

  摘要：

  本发明揭示了酚磷酸酶的有机硫调节剂及其在治疗疾病中的应用。

  公开号：

  US20050065118A1

文献信息

• Amide inhibitors of leukotriene A4 hydrolase
  申请人：Chen Ming

  公开号：US20070155727A1

  公开（公告）日：2007-07-05

  This invention is directed to compounds of formula (I): where r, q, R, R 2 , R 3 , R 4a , R 4b , R 4c , R 5a , R 5b , R 5c , R 6a , R 6b , R 6c , R 7 , R 8 , R 9 and R 10 are described herein, or pharmaceutically acceptable salts, solvates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A 4 hydrolase inhibitors and which are therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of using and preparing the compounds of the invention are also disclosed.

  本发明涉及式(I)的化合物：其中r、q、R、R2、R3、R4a、R4b、R4c、R5a、R5b、R5c、R6a、R6b、R6c、R7、R8、R9和R10如本文所述，或其药学上可接受的盐、溶剂化物、多晶体、铵离子、N-氧化物或前药；它们是白三烯A4水解酶抑制剂，因此在治疗炎症性疾病方面有用。本发明还揭示了包括本发明化合物的制药组合物以及使用和制备本发明化合物的方法。
• Cyclic guanidines, compositions containing such compounds and methods of use
  申请人：Merck & Co., Inc.

  公开号：US07301036B2

  公开（公告）日：2007-11-27

  The present invention relates to cyclic guanidines, compositions containing such compounds and methods of treatment. The compounds are glucagon receptor antagonists and thus are useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.

  本发明涉及环状胍，含有这种化合物的组合物以及治疗方法。这些化合物是糖高原受体拮抗剂，因此可用于治疗、预防或延迟2型糖尿病的发生。
• Antibacterial quinazoline compounds
  申请人：Isis Pharmaceuticals, Inc.

  公开号：US06156758A1

  公开（公告）日：2000-12-05

  Provided are compounds of formula (I) ##STR1## wherein X, Y and Z are independently CH or N; n is 0 or 1; R.sub.1 is selected from OH, alkoxy, aryloxy, aralkyloxy and guanidinyl; R.sub.2 and R.sub.3 are independently selected from H, halogen, amino, hydroxyl, nitro, cyano and carboxyl; R.sub.4 is H, alkyl or acyl; R.sub.5 is selected from H, hydroxyl, halogen, nitro, alkyl, alkoxy, amino, cyclic amino, alkylamino, arylamino and aralkylamino wherein the alkyl, aryl and cyclic moieties are optionally substituted; R.sub.6 and R.sub.7 are independently selected from H, alkyl, alkoxy, halogen and amino; and R.sub.8 and R.sub.9 are independently selected from H, C.sub.1-4 alkyl, alkoxy, acyl, acyloxy, alkoxycarbonyl, hydroxyl, halogen, amino and carboxyl. The compounds have therapeutic or prophylactic use for treating bacterial infection in mammals.

  提供的是化合物的公式（I）##STR1## 其中X、Y和Z独立地为CH或N；n为0或1；R.sub.1从OH、alkoxy、aryloxy、aralkyloxy和guanidinyl中选择；R.sub.2和R.sub.3独立地从H、卤素、氨基、羟基、硝基、氰基和羧基中选择；R.sub.4为H、烷基或酰基；R.sub.5从H、羟基、卤素、硝基、烷基、alkoxy、氨基、环氨基、烷基氨基、芳基氨基和aralkylamino中选择，其中烷基、芳基和环状基团可选择性地被取代；R.sub.6和R.sub.7独立地从H、烷基、alkoxy、卤素和氨基中选择；R.sub.8和R.sub.9独立地从H、C.sub.1-4烷基、alkoxy、酰基、酰氧基、alkoxycarbonyl、羟基、卤素、氨基和羧基中选择。这些化合物具有治疗或预防哺乳动物细菌感染的用途。
• Organosulfur inhibitors of tyrosine phosphatases
  申请人：Wang Jing

  公开号：US20050065118A1

  公开（公告）日：2005-03-24

  Organosulfur modulators of tyrosine phosphatases and their use in the treatment of disease are disclosed.

  本发明揭示了酚磷酸酶的有机硫调节剂及其在治疗疾病中的应用。